139 related articles for article (PubMed ID: 38353070)
1. Predicting risk of recurrence after resection of stage I intrahepatic cholangiocarcinoma.
Kawashima J; Sahara K; Shen F; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Cauchy F; Koerkamp BG; Matsuyama R; Endo I; Pawlik TM
J Gastrointest Surg; 2024 Jan; 28(1):18-25. PubMed ID: 38353070
[TBL] [Abstract][Full Text] [Related]
2. Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma.
Hu LS; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
J Surg Oncol; 2019 Jan; 119(1):21-29. PubMed ID: 30466151
[TBL] [Abstract][Full Text] [Related]
3. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
[TBL] [Abstract][Full Text] [Related]
4. Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma: Considering Alternative Treatment Approaches.
Tsilimigras DI; Sahara K; Wu L; Moris D; Bagante F; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Soubrane O; Koerkamp BG; Moro A; Sasaki K; Aucejo F; Zhang XF; Matsuyama R; Endo I; Pawlik TM
JAMA Surg; 2020 Sep; 155(9):823-831. PubMed ID: 32639548
[TBL] [Abstract][Full Text] [Related]
5. Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma.
Hu LS; Zhang XF; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
Ann Surg Oncol; 2019 Aug; 26(8):2549-2557. PubMed ID: 31020501
[TBL] [Abstract][Full Text] [Related]
6. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
[No Abstract] [Full Text] [Related]
7. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
[TBL] [Abstract][Full Text] [Related]
8. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a new prognostic immune-inflammatory-nutritional score for predicting outcomes after curative resection for intrahepatic cholangiocarcinoma: A multicenter study.
Zhu J; Wang D; Liu C; Huang R; Gao F; Feng X; Lan T; Li H; Wu H
Front Immunol; 2023; 14():1165510. PubMed ID: 37063918
[TBL] [Abstract][Full Text] [Related]
10. Should lymphadenectomy performed routinely in patients with primary intrahepatic cholangiocarcinoma undergoing curative hepatectomy? A retrospective cohort study with propensity-score matching analysis.
Huang S; Song JL; Li B; Yi PS; Yang J
BMC Surg; 2023 Nov; 23(1):364. PubMed ID: 38036995
[TBL] [Abstract][Full Text] [Related]
11. A novel prognostic system combining carbonic anhydrase II and preoperative CA19-9 for intrahepatic cholangiocarcinoma after curative resection.
Zhang J; Huang Q; Yang Y; Zhang J; Fang X; Yang Y; Liang H; Wang W; Wang Y
Cancer; 2023 Apr; 129(7):1030-1040. PubMed ID: 36625486
[TBL] [Abstract][Full Text] [Related]
12. Impact of body mass index on tumor recurrence among patients undergoing curative-intent resection of intrahepatic cholangiocarcinoma- a multi-institutional international analysis.
Merath K; Mehta R; Hyer JM; Bagante F; Sahara K; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Weiss MJ; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Ejaz A; Pawlik TM
Eur J Surg Oncol; 2019 Jun; 45(6):1084-1091. PubMed ID: 30871884
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors of recurrent intrahepatic cholangiocarcinoma after hepatectomy: A retrospective study.
Yuan ZB; Fang HB; Feng QK; Li T; Li J
World J Gastroenterol; 2022 Apr; 28(15):1574-1587. PubMed ID: 35582131
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection.
Li XH; Zhao CY; Zhou EL; Lin XJ
BMC Cancer; 2022 Nov; 22(1):1159. PubMed ID: 36357848
[TBL] [Abstract][Full Text] [Related]
15. Specific risk factors contributing to early and late recurrences of intrahepatic cholangiocarcinoma after curative resection.
Wang C; Pang S; Si-Ma H; Yang N; Zhang H; Fu Y; Yang G
World J Surg Oncol; 2019 Jan; 17(1):2. PubMed ID: 30606203
[TBL] [Abstract][Full Text] [Related]
16. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.
Hyder O; Marques H; Pulitano C; Marsh JW; Alexandrescu S; Bauer TW; Gamblin TC; Sotiropoulos GC; Paul A; Barroso E; Clary BM; Aldrighetti L; Ferrone CR; Zhu AX; Popescu I; Gigot JF; Mentha G; Feng S; Pawlik TM
JAMA Surg; 2014 May; 149(5):432-8. PubMed ID: 24599477
[TBL] [Abstract][Full Text] [Related]
17. Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study.
Zhang XF; Chakedis J; Bagante F; Beal EW; Lv Y; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
World J Surg; 2018 Mar; 42(3):849-857. PubMed ID: 28879598
[TBL] [Abstract][Full Text] [Related]
18. Postoperative Prognosis of Non-alcoholic Fatty Liver Disease-Associated Intrahepatic Cholangiocarcinoma: a Multi-center Propensity Score Matching Analysis.
Yu Q; Lei Z; Ma W; Yang F; Tang H; Xiao Q; Tang X; Si A; Yang P; Zhou N; Cheng Z
J Gastrointest Surg; 2023 Nov; 27(11):2403-2413. PubMed ID: 37582919
[TBL] [Abstract][Full Text] [Related]
19. Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy.
Song S; Kim K; Chie EK; Kim S; Park HJ; Yi NJ; Suh KS; Ha SW
Clin Transl Oncol; 2015 Oct; 17(10):825-9. PubMed ID: 26041722
[TBL] [Abstract][Full Text] [Related]
20. Predicting overall and recurrence-free survival in patients with intrahepatic cholangiocarcinoma using the MEGNA score: A multi-institutional analysis.
Shaikh CF; Alaimo L; Moazzam Z; Endo Y; Lima HA; Dawood Z; Munir MM; Pawlik TM
J Surg Oncol; 2023 Jan; 127(1):73-80. PubMed ID: 36106350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
